Hans-Peter Hartung

Professor and Chairman

Heinrich Heine University Düsseldorf

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (6)

Ulrike Weber-Stadlbauer

SWITZERLAND

View details

Yanhua Hu

Bristol-Myers Squibb

UNITED STATES

View details

Richard A. C. Hughes

UNITED KINGDOM

View details

Olaf Stuve

University of Texas Southwestern Medical Center

UNITED STATES

View details

Bruce Cree

Professor of Clinical Neurology

University of California, San Francisco

UNITED STATES

View details

Ludwig Kappos

Professor

University of Basel

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hans-Peter Hartung

Research Interests

Explore related searches

Contact this professor

Articles (13)

Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis

ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial

A review of Bruton’s tyrosine kinase inhibitors in multiple sclerosis

SARS‐CoV‐2 vaccination and infection in ozanimod‐treated participants with relapsing multiple sclerosis

Transgenic expression of the HERV-W envelope protein leads to polarized glial cell populations and a neurodegenerative environment

An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy

Correction to: The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis

The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis

Analysis of relapse by inflammatory Rasch‐built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy

Neurological update: treatment escalation in multiple sclerosis patients refractory to fingolimod—potentials and risks of subsequent highly active agents

Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management

Correction to “Hartung H‐P. Neuromyelitis Optica Spectrum Disorder: Therapeutic Innovations and Complex Decision‐Making.”

Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis

Collaborators (6)

Ulrike Weber-Stadlbauer

Yanhua Hu

Richard A. C. Hughes

Olaf Stuve

Bruce Cree

Ludwig Kappos

Make your next move.